Healthcare professionals should:
- Inform patients before starting treatment about the potential risk of severe increase in disability after stopping Gilenya.
- Patients should be carefully observed for evidence of an exacerbation of their MS and treated appropriately when Gilenya is stopped.
- Patients should be advised to seek immediate medical attention if they experience new or worsened symptoms of MS after Gilenya is stopped.
- Test for new or enhancing lesions by magnetic resonance imaging (MRI) if an increase in disability occurs and begin appropriate treatment as needed.
- Encourage patients to read the patient Medication Guide they receive with their Gilenya prescriptions, which explains the benefits and risks of the medicine.
- Patients who have been instructed to stop Gilenya, should contact their health professional immediately if you experience new or worsened symptoms.
- Patients should not stop taking the medicine on their own and should speak to their health professional first, as stopping treatment can lead to worsening MS symptoms.